Skip to content

Clinical trials

Hemorrhage trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Country / region: Brazil Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20093
20102
20111
20121
20134
20141
20153
20171
20182
20194
20201
20211
20222
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status7
Recruiting5
Enrolling by invitation2
Not yet recruiting2
Terminated2
Withdrawn1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo3
University of Sao Paulo General Hospital3
Hospital de Clinicas de Porto Alegre2
Sangart2
Anthos Therapeutics, Inc.1
AstraZeneca1
Boehringer Ingelheim1
Colgate Palmolive1
Federal University of Minas Gerais1
Federal University of São Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage34
Stroke5
Wounds and Injuries5
Atrial Fibrillation4
Blood Coagulation Disorders3
Acidosis, Lactic2
Gingivitis2
Periodontal Diseases2
Recurrence2
Sepsis2

Trials

Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.